HD-OPM Archive
Topics › Supplements & vitamins

JAMA RCT: high-dose vitamin D reduced disease activity in early multiple sclerosis

Louis Nervegna · Mar 10, 2025 · ♥ 16 reactions · 6 comments · original Facebook post
Supplements & vitamins
AI summary & key facts

Louis shares a JAMA trial in which oral cholecalciferol 100,000 IU every two weeks significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting MS. He speculates it may help other autoimmune diseases. The topic is not cardiovascular.

Vitamin D improves outcomes in multiple sclerosis in a very high quality RCT just published in JAMA.

This hints that it may treat other autoimmune diseases as well.

Quoted:

“Oral cholecalciferol 100 000 IU every 2 weeks significantly reduced disease activity in CIS and early relapsing-remitting MS. These results warrant further investigation, including the potential role of pulse high-dose vitamin D as add-on therapy.”

#vitamindHD #msHD #autoimmuneHD #jamaHD

Research cited

Shared from JAMA · original post

Oral high-dose vitamin D reduced disease activity in patients with clinically isolated syndrome and in early relapsing-remitting multiple sclerosis.

Paper · JAMA · 2025High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple SclerosisImportance Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting. Objective To evaluate the efficacy of high-dose cholecalciferol as monotherapy in reducing disease activity in patients with clinically isolated syndrome (CIS) typical for MS. Design, Setting, and Participants The D-Lay MS trial…jamanetwork.comNo photo description available.
← newer: Seed oils don't raise inflammation markers; butter linked toolder: Fecal transplants show promise against cancer; CVD and diabe →